Keyphrases
Early Intervention
80%
Implant Loosening
80%
Inflammation
80%
Early Detection
80%
Orthopedic Implants
80%
Theranostics
60%
N-(2-hydroxypropyl)methacrylamide Copolymers
60%
Peri-implant
40%
Wear Particles
40%
Orthopedics
40%
Inflammatory Diseases
40%
Optimal Structural Parameters
25%
Peri-implant Bone Quality
25%
Lymphatic Clearance
25%
Efficacy Profile
20%
Pharmacokinetics
20%
Cell-mediated
20%
Off-target Toxicity
20%
Water-soluble
20%
Intraosseous
20%
Femoral Implant
20%
Early Diagnosis
20%
Diagnosis Treatment
20%
Clinical Failure
20%
Passive Targeting
20%
Theranostic System
20%
Functional Properties
20%
Inflammatory Disorders
20%
Sequestration
20%
Loosening Failure
20%
Biodistribution Studies
20%
Cleavage Kinetics
20%
Theranostic Tools
20%
Theranostic Approach
20%
Management Paradigms
20%
Effective Treatment
20%
Safety Profile
20%
Peri-implant Osteolysis
20%
Intracellular Signaling Molecules
20%
Total Joint Replacement
20%
Aseptic Implant Loosening
20%
Structural Properties
20%
In Vivo Efficacy
20%
Drug Delivery System
20%
Highly Sensitive
20%
Macromolecules
20%
Cellular Uptake
20%
In Vivo Safety
20%
Disease Activity
20%
Inflammatory Cells
20%
High-throughput Detection
20%
Autoimmune Disease
20%
Implant Model
20%
Vascular Leakage
20%
Novel Mechanism
20%
Wear Particle-induced Osteolysis
20%
Disease Progression
20%
Medicine and Dentistry
Implant
100%
Orthopedics
100%
N (2 Hydroxypropyl)methacrylamide Copolymer
75%
Inflammatory Disorder
50%
Extravasation
50%
Osteolysis
50%
Conjugate
25%
Pharmacokinetics
25%
Lymph Duct
25%
Biodistribution
25%
Sensitive Detection
25%
Intracellular Signaling
25%
Dexamethasone
25%
Disease Exacerbation
25%
Early Diagnosis
25%
Total Arthroplasty
25%
Signaling Molecule
25%
Drug Delivery System
25%
Autoimmune Disease
25%
Disease Activity
25%
Inflammatory Cell
25%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Implant
100%
N (2 Hydroxypropyl)methacrylamide Copolymer
75%
Inflammatory Disease
50%
Extravasation
50%
Pharmacokinetics
25%
Autoimmune Disease
25%
Drug Delivery System
25%
Biodistribution
25%
Dexamethasone
25%
Disease Activity
25%
Disease Exacerbation
25%